A detailed history of 2 Xideas Ag transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, 2 Xideas Ag holds 37,144 shares of CRL stock, worth $6.9 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
37,144
Previous 42,410 12.42%
Holding current value
$6.9 Million
Previous $8.76 Million 16.49%
% of portfolio
1.07%
Previous 1.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $989,797 - $1.29 Million
-5,266 Reduced 12.42%
37,144 $7.32 Million
Q2 2024

Aug 14, 2024

SELL
$206.39 - $268.73 $23,941 - $31,172
-116 Reduced 0.27%
42,410 $8.76 Million
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $2.57 Million - $3.46 Million
-12,638 Reduced 22.91%
42,526 $11.5 Million
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $570,390 - $828,058
-3,467 Reduced 5.91%
55,164 $13 Million
Q3 2023

Nov 07, 2023

BUY
$194.44 - $217.61 $151,857 - $169,953
781 Added 1.35%
58,631 $11.5 Million
Q2 2023

Aug 10, 2023

BUY
$183.71 - $210.25 $1.71 Million - $1.96 Million
9,330 Added 19.23%
57,850 $12.2 Million
Q1 2023

May 11, 2023

BUY
$191.89 - $259.92 $372,074 - $503,984
1,939 Added 4.16%
48,520 $9.79 Million
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $1,773 - $2,250
9 Added 0.02%
46,581 $10.1 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $116,214 - $159,593
-637 Reduced 1.35%
46,572 $9.17 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $977,986 - $1.45 Million
4,791 Added 11.29%
47,209 $10.1 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $1.68 Million - $2.38 Million
6,561 Added 18.3%
42,418 $12 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $12.6 Million - $16.1 Million
35,857 New
35,857 $13.5 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track 2 Xideas Ag Portfolio

Follow 2 Xideas Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 2 Xideas Ag, based on Form 13F filings with the SEC.

News

Stay updated on 2 Xideas Ag with notifications on news.